The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(8-methyl-5H-pyrido[4,3-b]indol-5-yl)-1-(10H-phenothiazin-10-yl)propan-1-one ID: ALA4855045
PubChem CID: 164616318
Max Phase: Preclinical
Molecular Formula: C27H21N3OS
Molecular Weight: 435.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2c(c1)c1cnccc1n2CCC(=O)N1c2ccccc2Sc2ccccc21
Standard InChI: InChI=1S/C27H21N3OS/c1-18-10-11-21-19(16-18)20-17-28-14-12-22(20)29(21)15-13-27(31)30-23-6-2-4-8-25(23)32-26-9-5-3-7-24(26)30/h2-12,14,16-17H,13,15H2,1H3
Standard InChI Key: OHLLCAOZLCURLY-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 37 0 0 0 0 0 0 0 0999 V2000
41.6639 -26.3730 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.6639 -24.7386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.3692 -25.1513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3676 -25.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0718 -26.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7781 -25.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7757 -25.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0709 -24.7449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9586 -25.9685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9612 -25.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2574 -24.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5506 -25.1512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5520 -25.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2564 -26.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6625 -23.9214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3695 -23.5116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.9540 -23.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9526 -22.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2442 -22.2895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4960 -22.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9497 -22.0202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1526 -22.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9007 -22.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4520 -23.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2471 -23.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3508 -21.3157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1513 -21.4820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6936 -20.8726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4366 -20.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6322 -19.9336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0934 -20.5443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1017 -23.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
9 1 1 0
1 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
2 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 27 1 0
26 21 1 0
20 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
23 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.55Molecular Weight (Monoisotopic): 435.1405AlogP: 6.72#Rotatable Bonds: 3Polar Surface Area: 38.13Molecular Species: BASEHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.57CX LogP: 5.50CX LogD: 4.70Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.32Np Likeness Score: -1.12
References 1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122 ] [10.1016/j.bmc.2021.116355 ]